Remedicalizing Cannabis

When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines. With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedicalizing Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedicalization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism. Remedicalizing Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today’s debates about cannabis.

When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines. With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedicalizing Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedicalization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism. Remedicalizing Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today’s debates about cannabis.

Despite having the highest rates of cannabis use in the continent, France enforces the most repressive laws against the drug in all of Europe. Perhaps surprisingly, France was once the epicentre of a global movement to medicalize cannabis, specifically hashish, in the treatment of disease. In Taming Cannabis David Guba examines how nineteenth-century French authorities routinely blamed hashish consumption, especially among Muslim North Africans, for behaviour deemed violent and threatening to the social order. This association of hashish with violence became the primary impetus for French pharmacists and physicians to tame the drug and deploy it in the homeopathic treatment of mental illness and epidemic disease during the 1830s and 1840s. Initially heralded as a wonder drug capable of curing insanity, cholera, and the plague, hashish was deemed ineffective against these diseases and fell out of repute by the middle 1850s. The association between hashish and Muslim violence, however, remained and became codified in French colonial medicine and law by the 1860s: authorities framed hashish as a significant cause of mental illness, violence, and anti-state resistance among indigenous Algerians. As the French government looks to reform the nation's drug laws to address the rise in drug-related incarceration and the growing popular demand for cannabis legalization, Taming Cannabis provides a timely and fascinating exploration of the largely untold and living history of cannabis in colonial France.

In the 1950s, the causal link between smoking and lung cancer surfaced in medical journals and mainstream media. Yet the best years for the Canadian cigarette industry were still to come, as per capita cigarette consumption rose steadily in the 1960s and 1970s. In Cigarette Nation, Daniel Robinson examines the vibrant and contentious history of smoking to discover why Canadians continued to light up despite the publicized health risks. Highlighting the prolific marketing and advertising practices that helped make smoking a staple of everyday life, Robinson explores socio-cultural aspects of cigarette use from the 1930s to the 1950s and recounts the views and actions of tobacco executives, government officials, and Canadian smokers as they responded to mounting evidence that cigarette use was harmful. The persistence of smoking owes to such factors as product development, marketing and retailing innovation, public relations, sponsored science, and government inaction. Domestic and international tobacco firms worked to furnish Canadian smokers with hope and doubt: hope in the form of reassuring marketing, as seen with light and mild cigarette brands, and doubt by means of disinformation campaigns attacking medical research and press accounts that aligned cigarettes with serious disease. Drawing on a wide range of primary sources, including thousands of industry records released during a landmark tobacco class-action trial in 2015, Cigarette Nation documents in rich detail the history of one of Canada’s foremost public health issues.

This edited collection brings together the social dimensions of three key aspects of recent biomedical advance in HIV research: Treatment as Prevention (TasP), new technologies such as Pre-Exposure Prophylaxis (PrEP), and the Undetectable equals Untransmittable (U=U) movement. The growth of new forms of biomedical HIV prevention has created hope for the future, signalling the possibility of a world without AIDS. In this context, the volume discusses the profound social, political and ethical dilemmas raised by such advances, which are to do with readiness, access, equity and availability. It examines how HIV prevention has been, and is, re-framed in policy, practice and research, and asks: How best can new biomedical technologies be made available in a profoundly unequal world? What new understandings of responsibility and risk will emerge as HIV becomes a more manageable condition? What new forms of blame will emerge in a context where the technologies to prevent HIV exist, but are not always used? How best can we balance public health’s concern for adherence and compliance with the rights of individuals to decide on what is best for themselves and others? Few of these questions have thus far received serious consideration in the academic literature. The editors, all leaders in the social aspects of HIV, have brought together an innovative and international collection of essays by top thinkers and practitioners in the field of HIV. This book is an important resource for academics and professionals interested in HIV research. Chapters "Anticipating Policy, Orienting Services, Celebrating Provision: Reflecting on Scotland’s PrEP Journey", "How the science of HIV treatment-as-prevention restructured PEPFAR’s strategy: The case for scaling up ART in ‘epidemic control’ countries", "Stigma and confidentiality indiscretions: Intersecting obstacles to the delivery of Pre-Exposure Prophylaxis to adolescent girls and young women in east Zimbabwe" and "The drive to take an HIV test in rural Uganda: a risk to prevention for young people?" are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

In the nineteenth century, drug consumption permeated French society to produce a new norm: the chemical enhancement of modern life. French citizens empowered themselves by seeking pharmaceutical relief for their suffering and engaging in self-medication. Doctors and pharmacists, meanwhile, fashioned themselves as gatekeepers to these potent drugs, claiming that their expertise could shield the public from accidental harm. Despite these efforts, the unanticipated phenomenon of addiction laid bare both the embodied nature of the modern self and the inherent instability of the notions of individual free will and responsibility. Drugging France explores the history of mind-altering drugs in medical practice between 1840 and 1920, highlighting the intricate medical histories of opium, morphine, ether, chloroform, cocaine, and hashish. While most drug histories focus on how drugs became regulated and criminalized as dangerous addictive substances, Sara Black instead traces the spread of these drugs through French society, demonstrating how new therapeutic norms and practices of drug consumption transformed the lives of French citizens as they came to expect and even demand pharmaceutical solutions to their pain. Through self-experimentation, doctors developed new knowledge about these drugs, transforming exotic botanical substances and unpredictable chemicals into reliable pharmaceutical commodities that would act on the mind and body to modify pain, sensation, and consciousness. From the pharmacy counter to the boudoir, from the courtroom to the operating theatre, from the battlefield to the birthing chamber, Drugging France explores how everyday encounters with drugs reconfigured how people experienced their own minds and bodies.

Early modern Russians preferred one method of treating the sick above all others: prescribing drugs. The Moscow court sourced pharmaceuticals from Asia, Africa, Western Europe, and the Americas, in addition to its own sprawling empire, to heal its ailing tsars. Mixing Medicines explores the dynamic and complex world of early modern Russian medical drugs, from its enthusiasm for newly imported American botanicals to its disgust at Western European medicines made from human corpses. Clare Griffin draws from detailed apothecary records to shed light on the early modern Russian Empire’s role in the global trade in medical drugs. Chapters follow the trade and use of medical ingredients through networks that linked Moscow to Western Europe, Asia, and the Americas; the transformation of natural objects, such as botanicals and chemicals, into medicines; the documentation and translation of medical knowledge; and Western European influence on Russian medical practices. Looking beyond practitioners, texts, and ideas to consider how materials of medicine were used by one of the early modern world’s major empires provides a novel account of the global history of early modern medicine. Mixing Medicines offers unique insight into how the dramatic reshaping of global trade touched the day-to-day lives of the people living in early modern Russia.

Dry Bones Breathe: Gay Men Creating Post-AIDS Identities and Cultures breaks new ground in offering an original and insightful interpretation of gay men’s shifting experience of the AIDS epidemic. From Dry Bones Breathe, you’ll gain a deeper understanding of current community debates focused on circuit parties, unprotected sex, and gay men’s sexual cultures, and you will learn how social, political, and biomedical changes are dramatically transforming gay identities and cultures. Dry Bones Breathe is Eric Rofes’explosive follow-up to Reviving the Tribe, a book which broke open debates in gay communities around the world about sex, identity, and gay men’s relationship to AIDS. In this volume, Rofes contends that most gay men no longer experience AIDS as the crisis they did during the 1980s. Gay men often attribute this shift to the advent of protozoa inhibitors, but Rofes explains how other factors, including the epidemic’s predicted trajectory, new treatments for opportunistic infections, the passage of time, and the increasing diversity of gay men inhabiting communities throughout the country have set in motion the transformation of gay life. AIDS organizations and gay leaders, however, continue to assert that gay men experience AIDS as an emergency, resulting in a tremendous dissonance between gay leaders and their communities. In the midst of this controversy, Dry Bones Breathe lets you share in stories of hope and recovery and a new vision for AIDS work that demands a radical redesign of prevention, care, and activism. Dry Bones Breathe tackles several other issues concerning the powerful shifts occurring in gay communities and cultures by: explaining why an understanding of the terms “post-AIDS” and “post-crisis” is crucial to interpreting contemporary gay male cultures and what Australian prevention theorists have to offer gay men in the United States describing the “Protozoa Moment” and exploring how a dangerous obsession with pharmaceuticals is leading many to mistakenly attribute all changes in gay men’s cultures to combination therapies examining the writings of Larry Kramer, Andrew Sullivan, Michelangelo Signorile, and Gabriel Rightly to illustrate how the crisis construct has unleashed a backlash against gay sexual cultures discussing the dramatic diminution in gay men’s AIDS-related deaths in epicenter cities and the impact of shrinking obituary pages on gay men’s mental health exploring the diverse relationships to the epidemic forged by young gay men, gay men of color, gay men from rural or small towns, and middle-aged men not infected with HI detailing how HI prevention and service organizations targeting gay men must redesign their mission and restructure their work In response to continuing efforts to direct gay men back into a state of emergency, Dry Bones Breathe suggests that long-term prevention efforts must be constructed around something other than a crisis. While AIDS organizations look at gay men’s diminished participation in AIDS activism, Rofes argues that these organizations should face how they have distanced themselves from the reality of most gay men’s lives. From stories and experiences full of hope, anger, sadness, and strength, Dry Bones Breathe will teach you about gay men who no longer base their identities and cultures solely around AIDS.